Back
MoonLake Immunotherapeutics Stock Price Chart
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
15
MLTX
MoonLake Immunotherapeutics
Last Price:
$43.94
Seasonality Move:
-5.84%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing slight buying pressure.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.71 | Sell |
| 20-day SMA: | 50.13 | Sell |
| 50-day SMA: | 51.48 | Sell |
| 200-day SMA: | 46.82 | Sell |
| 8-day EMA: | 45.7 | Sell |
| 20-day EMA: | 48.75 | Sell |
| 50-day EMA: | 50.27 | Sell |
| 200-day EMA: | 48.57 | Sell |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.35 | Sell |
| Relative Strength Index (14 RSI): | 35.92 | Sell |
| Chaikin Money Flow: | 216794 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.89 - 54.75) | Sell |
| Bollinger Bands (100): | (47.13 - 53.45) | Sell |
MoonLake Immunotherapeutics Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 43.81 while MLTX 8-day simple moving average is 45.71, which is a Sell signal.
-
The stock price of MLTX is 43.81 while MoonLake Immunotherapeutics 20-day SMA is 50.13, which makes it a Sell.
-
MoonLake Immunotherapeutics 50-day simple moving average is 51.48 while MLTX share price is 43.81, making it a Sell technically.
-
MLTX stock price is 43.81 and MoonLake Immunotherapeutics 200-day simple moving average is 46.82, creating a Sell signal.
MLTX Technical Analysis vs Fundamental Analysis
Sell
15
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a SellThe current MoonLake Immunotherapeutics [MLTX] share price is $43.81. The Score for MLTX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
2.8B
Price in USD:
43.81
Share Volume:
807.6K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
64.98
52-Week Low:
37.55
Sell
15
MoonLake Immunotherapeutics (MLTX)
is a Sell
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?The MoonLake Immunotherapeutics stock price is 43.81 USD today.
-
Will MLTX stock go up or go down?MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is MoonLake Immunotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 43.81 while MLTX 8-day exponential moving average is 45.70, which is a Sell signal.
-
The stock price of MLTX is 43.81 while MoonLake Immunotherapeutics 20-day EMA is 48.75, which makes it a Sell.
-
MoonLake Immunotherapeutics 50-day exponential moving average is 50.27 while MLTX share price is 43.81, making it a Sell technically.
-
MLTX stock price is 43.81 and MoonLake Immunotherapeutics 200-day simple moving average is 48.57, creating a Sell signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and a decrease next year of $0.83 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
-
MLTX Moving Average Covergence Divergence (MACD) indicator is -2.35, suggesting MoonLake Immunotherapeutics is a Sell
-
MoonLake Immunotherapeutics Relative Strength Index (RSI) is 35.92, which suggest MoonLake Immunotherapeutics is oversold
-
The Bollinger Bands (25) for MoonLake Immunotherapeutics is (46.89 - 54.75), which suggest MoonLake Immunotherapeutics is a Sell
-
The Bollinger Bands (100) for MoonLake Immunotherapeutics is (47.13 - 53.45), which suggest MoonLake Immunotherapeutics is a Sell
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.